Advertisement

The AAHKS Clinical Research Award: What Are the Costs of Knee Osteoarthritis in the Year Prior to Total Knee Arthroplasty?

Published:January 17, 2017DOI:https://doi.org/10.1016/j.arth.2017.01.011

      Abstract

      Background

      Despite American Academy of Orthopaedic Surgeons Clinical Practice Guidelines (CPGs) related to the non-arthroplasty management of osteoarthritis (OA) of the knee, non-recommended treatments remain in common use. We sought to determine the costs associated with non-arthroplasty management of knee OA in the year prior to total knee arthroplasty (TKA) and stratify them by CPG recommendation status.

      Methods

      The Humana database was reviewed from 2007 to 2015 for primary TKA patients. Costs for hyaluronic acid (HA) and corticosteroid injections, physical therapy, braces, wedge insoles, opioids, non-steroidal anti-inflammatories, and tramadol in the year prior to TKA were calculated. Cost was defined as reimbursement paid by the insurance provider. Costs were analyzed relative to the overall non-inpatient costs for knee OA and categorized based on CPG recommendations.

      Results

      In total 86,081 primary TKA patients were analyzed and 65.8% had at least one treatment in the year prior to TKA. Treatments analyzed made up 57.6% of the total non-inpatient cost of knee OA in the year prior to TKA. Only 3 of the 8 treatments studied have a strong recommendation for their use (physical therapy, non-steroidal anti-inflammatories, tramadol) and costs for these interventions represented 12.2% of non-inpatient knee OA cost. In contrast, 29.3% of the costs are due to HA injections alone, which are not supported by CPGs.

      Conclusion

      In the year prior to TKA, over half of the non-inpatient costs associated with knee OA are from injections, therapy, prosthetics, and prescriptions. Approximately 30% of this is due to HA injections alone. If only interventions recommend by the CPG are utilized then costs associated with knee OA could be decreased by 45%.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Arthroplasty
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Zhang Y.
        • Jordan J.M.
        Epidemiology of osteoarthritis.
        Clin Geriatr Med. 2010; 26: 355
        • Ma V.Y.
        • Chan L.
        • Carruthers K.J.
        Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and back pain.
        Arch Phys Med Rehabil. 2014; 95: 986
        • Neogi T.
        The epidemiology and impact of pain in osteoarthritis.
        Osteoarthritis Cartilage. 2013; 21: 1145
        • Neogi T.
        • Zhang Y.
        Epidemiology of osteoarthritis.
        Rheum Dis Clin North Am. 2013; 39: 1
        • Bedair H.
        • Cha T.D.
        • Hansen V.J.
        Economic benefit to society at large of total knee arthroplasty in younger patients: a Markov analysis.
        J Bone Joint Surg Am. 2014; 96: 119
        • Losina E.
        • Toure H.
        • Uhler L.M.
        • et al.
        • ART-LINC Collaboration of International Epidemiological Database to Evaluate AIDS (IeDEA); CEPAC International Investigators
        Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Cote d'Ivoire appraisal.
        PLoS Med. 2009; 6: e1000173
        • Mather 3rd, R.C.
        • Hug K.T.
        • Orlando L.A.
        • et al.
        Economic evaluation of access to musculoskeletal care: the case of waiting for total knee arthroplasty.
        BMC Musculoskelet Disord. 2014; 15: 22
        • Nwachukwu B.U.
        • Bozic K.J.
        • Schairer W.W.
        • et al.
        Current status of cost utility analyses in total joint arthroplasty: a systematic review.
        Clin Orthop Relat Res. 2015; 473: 1815
        • Ruiz Jr., D.
        • Koenig L.
        • Dall T.M.
        • et al.
        The direct and indirect costs to society of treatment for end-stage knee osteoarthritis.
        J Bone Joint Surg Am. 2013; 95: 1473
        • Marsland D.
        • Mumith A.
        • Barlow I.W.
        Systematic review: the safety of intra-articular corticosteroid injection prior to total knee arthroplasty.
        Knee. 2014; 21: 6
        • Dhawan A.
        • Mather 3rd, R.C.
        • Karas V.
        • et al.
        An epidemiologic analysis of clinical practice guidelines for non-arthroplasty treatment of osteoarthritis of the knee.
        Arthroscopy. 2014; 30: 65
        • Cohen J.R.
        • Bradley A.T.
        • Lieberman J.R.
        Preoperative interventions and charges before total knee arthroplasty.
        J Arthroplasty. 2016; 31: 2730
        • Jevsevar D.S.
        Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition.
        J Am Acad Orthop Surg. 2013; 21: 571
        • Bedard N.A.
        • Pugely A.J.
        • Elkins J.M.
        • et al.
        The John N. Insall Award: do intraarticular injections increase the risk of infection after TKA?.
        Clin Orthop Relat Res. 2017; 475: 45
        • Bozic K.J.
        Value-based healthcare and orthopaedic surgery.
        Clin Orthop Relat Res. 2012; 470: 1004
        • Cancienne J.M.
        • Werner B.C.
        • Luetkemeyer L.M.
        • et al.
        Does timing of previous intra-articular steroid injection affect the post-operative rate of infection in total knee arthroplasty?.
        J Arthroplasty. 2015; 30: 1879
        • da Costa B.R.
        • Nuesch E.
        • Kasteler R.
        • et al.
        Oral or transdermal opioids for osteoarthritis of the knee or hip.
        Cochrane Database Syst Rev. 2014; 9: CD003115
        • Zywiel M.G.
        • Stroh A.
        • Yong Lee S.
        • et al.
        Chronic opioid use prior to total knee arthroplasty.
        J Bone Joint Surg Am. 2011; 93: 1988
        • Nguyen L.L.
        • Sing D.C.
        • Bozic K.J.
        Preoperative reduction of opioid use before total joint arthroplasty.
        J Arthroplasty. 2016; 31: 282

      Linked Article